Larson Financial Group LLC Deciphera Pharmaceuticals, Inc. Transaction History

Larson Financial Group LLC

  • $1.75 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$13.58 - $17.36 $719 - $920
-53 Reduced 29.94%
124 $1,000
Q3 2022

Nov 03, 2022
SELL
$12.38 - $20.23 $12,404 - $20,270
-1,002 Reduced 84.99%
177 $3,000
Q2 2022

Aug 04, 2022
BUY
$9.11 - $13.98 $10,740 - $16,482
1,179 New
1,179 $16,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email